Disease: Systemic mastocytosis
- A 48-Year-Old Man With a Hip Fracture and Skin Rash: A Case Report
- A case of indolent systemic mastocytosis responding to treatment with Avapritinib
- A clinical, morphological and molecular study of 70 patients with gastrointestinal involvement in systemic mastocytosis
- A multi-center retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML
- A multicenter retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML
- A Review of the Clinical Features and Management of Systemic Congenital Mastocytosis through the Presentation of An Unusual Prenatal-Onset Case
- A study of the safety and effectiveness of lirentelimab as a treatment for people with indolent systemic mastocytosis
- Acute mast cell leukemia without KIT D816V mutation and lack of CD2 and CD25-a case report of rare entity
- Advanced systemic mastocytosis-Revised classification, new drugs and how we treat
- Aggressive systemic mastocytosis with multiple organ involvement: a case report
- Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation
- Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee
- Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries
- Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell-Mediated Reactions
- An unusual presentation of systemic mastocytosis in a myelolipoma
- An Unusual Transition from Cutaneous to Systemic Mastocytosis in a Pediatric Patient
- An Unusual Yet Treatable Cause of Recurrent Abdominal Pain
- Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts
- Avapritinib treatment of aggressive systemic mastocytosis with a novel KIT exon 17 mutation
- Avapritinib versus Placebo in Indolent Systemic Mastocytosis
- Bullous Mastocytosis: A Rare Variant of Diffuse Cutaneous Mastocytosis
- Case Report: Mast cell anergy: absence of symptoms after accidental re-exposure to amoxicillin/clavulanic acid 3 days after anaphylaxis
- Challenges in the Diagnosis of Cutaneous Mastocytosis
- Characteristics of an ethnically diverse cohort of children with pediatric cutaneous mastocytosis: One institution's experience
- Cladribine (2-CdA) improves cutaneous manifestations, DLQI and MC-QoL of patients with mastocytosis
- Cladribine improves cutaneous manifestations, Dermatology Life Quality Index, and Mastocytosis Quality of Life of patients with mastocytosis
- Clinical impact of cytomorphology in mast cell leukemia
- Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis
- Current Challenges in the Diagnosis of Pediatric Cutaneous Mastocytosis
- Diagnosis and management of systemic mastocytosis in a community hematology setting
- Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association o
- Diagnosis of systemic mastocytosis with cryptic deletion of TET2 and DNMT3A resulting from unbalanced translocation
- Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders
- Diffuse Cutaneous Mastocytosis: A Current Understanding of a Rare Disease
- Drug and Venom Allergy in Mastocytosis
- Effect of Gender and Special Considerations for Women in Mastocytosis and Anaphylaxis
- Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot study
- Epidemiology of mastocytosis: a population-based study (Sweden)
- Evaluation of a diagnostic algorithm for mastocytosis in skin biopsies and CD25 expression in skin mast cells of 49 patients followed up at a Tertiary Hospital in Sao Paulo, Brazil
- Factor VII Deficiency in Systemic Mastocytosis with an Associated Myeloid Neoplasm
- Fatal and Near Fatal Anaphylaxis - Data from the European Anaphylaxis Registry and National Health Statistics
- Fatal and Near-Fatal Anaphylaxis: Data From the European Anaphylaxis Registry and National Health Statistics
- Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis
- Gastrointestinal Disease in Mastocytosis
- Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment
- Genome-Wide DNA Methylation and Gene Expression in Patients with Indolent Systemic Mastocytosis
- Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases
- Hereditary Alpha Tryptasemia: Validation of a Single-Well Multiplex Digital Droplet PCR Assay in a Cohort of Symptomatic Patients
- Histological characterization of liver involvement in systemic mastocytosis
- How I diagnose systemic mastocytosis
- Intestinal perforation secondary to systemic mastocytosis: Report of an exceptional case
- KIT Mutations and Other Genetic Defects in Mastocytosis: Implications for Disease Pathology and Targeted Therapies
- KIT-mutated pediatric core-binding factor systemic mastocytosis-acute myeloid leukemia treated with avapritinib and decitabine
- Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders
- Luteolin Is More Potent than Cromolyn in Their Ability to Inhibit Mediator Release from Cultured Human Mast Cells
- Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms
- Mast Cell Disorders of the Gastrointestinal Tract: Clarity out of Chaos
- Mast Cell-Targeting Therapies in Mast Cell Activation Syndromes
- Mastocytoma
- Mastocytosis demystified
- Mastocytosis in the skin in dogs: A multicentric case series
- Mastocytosis-a frequently unrecognized disease
- Mastocytosis: Aiming for the Right Targets
- Measuring Symptom Severity and Quality of Life in Mastocytosis
- Metformin: A potential adjunct for treatment of systemic mastocytosis
- Midostaurin drug interaction profile: a comprehensive assessment of CYP3A, CYP2B6, and CYP2C8 drug substrates, and oral contraceptives in healthy participants
- Multicolor flow cytometric immunophenotyping is highly sensitive and specific in identifying aberrant mast cells in the diagnostic workup of systemic mastocytosis
- Nerve Growth Factor and Autoimmune Diseases
- No indication of aberrant neutrophil extracellular trap release in indolent or advanced systemic mastocytosis
- Papular-purpuric "gloves and socks" syndrome in systemic mastocytosis treated with imatinib: a diagnostic challenge
- Pediatric and Hereditary Mastocytosis
- Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in <em>KIT</em> D816V-Negative Advanced Systemic Mastocytosis
- Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in KIT D816V-Negative Advanced Systemic Mastocytosis
- Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry
- Recent Advances in the Therapeutic Management of Advanced Systemic Mastocytosis
- Renal Extramedullary Hematopoiesis in Mast Cell Leukemia with Bone Marrow Fibrosis
- Reply to: Successful Isatuximab Desensitization in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis
- Reversible Elevation of Tryptase Over the Individual's Baseline: Why is It the Best Biomarker for Severe Systemic Mast Cell Activation and MCAS?
- Review and Updates on Systemic Mastocytosis and Related Entities
- Safety of a mRNA COVID-19 Vaccine in Patients with Indolent Systemic Mastocytosis
- Salivary Cystatin D Interactome in Patients with Systemic Mastocytosis: An Exploratory Study
- Septic Peritonitis Secondary to Neoplasia in Two Canine Cancer-Bearing Patients Lacking Gastrointestinal and Hepatic Organ Rupture
- Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM
- Splinter haemorrhages in a patient with systemic mastocytosis and hypereosinophilia
- Standardized indolent systemic mastocytosis evaluations across a healthcare system: implications for screening accuracy
- Successful isatuximab desensitization in a patient with refractory multiple myeloma and indolent systemic mastocytosis
- Systemic Mastocytosis
- Systemic mastocytosis: dying or survivin
- T cell phenotype and lack of eosinophilia are not uncommon in extramedullary myeloid/lymphoid neoplasms with ETV6::FLT3 fusion: a case report and review of the literature
- T-cell immune profile in blood of systemic mastocytosis: Association with disease features
- The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis
- The diagnostic workup for systemic mastocytosis differs from consensus recommendations: Results of a worldwide survey
- The influence of nutritional habits, body mass index and intestinal microbiota in mastocytosis on clinical symptoms using conventional culture and next generation sequencing
- The Pivotal Role of Whole Genome and Transcriptome Sequencing in a Rare Case of Systemic Mastocytosis with Associated Myelodysplastic/Myeloproliferative Neoplasm with Neutrophilia
- The Prevalence Of Osteoporosis Is Low In Adult Cutaneous Mastocytosis Patients
- TNF alpha promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis
- Tumor necrosis factor alpha promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis
- Tyrosine Kinase Inhibitors in Non-advanced Systemic Mastocytosis
- Urticaria pigmentosa and systemic mastocytosis
- When Mast Cells Run Amok: A Comprehensive Review and Case Study on Severe Neonatal Diffuse Cutaneous Mastocytosis